MSH|^~\&|||||20160805102500-0600||VXU^V04^VXU_V04|1cuT-A.01.01.3n|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS
PID|1||1234^^^AIRA^MR||Pecos^Sawyer^Kyoko^^^^L|Marion^Valisa^^^^^M|20150425|F||2106-3^White^CDCREC|350 Greene Cir^^Little Lake^MI^49833^USA^P||^PRN^PH^^^906^3464569|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||N
PD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20160805|||A|20160805|20160805|
NK1|1|Pecos^Valisa^Marion^^^^L|MTH^Mother^HL70063|350 Greene Cir^^Little Lake^MI^49833^USA^P|^PRN^PH^^^906^3464569|
ORC|RE||F81S3495.3^AIRA|
RXA|0|1|20150425||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|A|
ORC|RE||F81S3495.3^AIRA|
RXA|0|1|20150625||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|A|
ORC|RE||F81S3495.3^AIRA|
RXA|0|1|20150625||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|A|
ORC|RE||F81S3495.3^AIRA|
RXA|0|1|20150625||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|A|
ORC|RE||F81S3495.3^AIRA|
RXA|0|1|20150625||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|A|
ORC|RE||F81S3495.3^AIRA|
RXA|0|1|20150625||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|A|
ORC|RE||F81S3495.3^AIRA|
RXA|0|1|20150625||10^IPV^CVX|999|||01^Historical^NIP001|||||||||||CP|A|
ORC|RE||F81S3495.3^AIRA|
RXA|0|1|20150825||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|A|
ORC|RE||F81S3495.3^AIRA|
RXA|0|1|20150825||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|A|
ORC|RE||F81S3495.3^AIRA|
RXA|0|1|20150825||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|A|
ORC|RE||F81S3495.3^AIRA|
RXA|0|1|20150825||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|A|
ORC|RE||F81S3495.3^AIRA|
RXA|0|1|20150825||10^IPV^CVX|999|||01^Historical^NIP001|||||||||||CP|A|
ORC|RE||F81S3495.3^AIRA|
RXA|0|1|20151025||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|A|
ORC|RE||F81S3495.3^AIRA|
RXA|0|1|20151025||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|A|
ORC|RE||F81S3495.3^AIRA|
RXA|0|1|20151025||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|A|
ORC|RE||F81S3495.3^AIRA|
RXA|0|1|20151025||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|A|
ORC|RE||F81S3495.3^AIRA|
RXA|0|1|20151025||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|A|
ORC|RE|1234^AIRA|F81S3495.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362
RXA|0|1|20160805||120^DTaP-Hib-IPV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||983BG|20170430|PMC^Sanofi^MVX|||CP|A|
RXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163|
OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20160805
OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20160805|||VXC40^per immunization^CDCPHINVS
OBX|3|CE|69764-9^Document Type^LN|3|253088698300026411151105^Multi Pediatric Vaccines VIS^cdcgs1vis||||||F|||20160805
OBX|4|DT|29769-7^Date Vis Presented^LN|3|20160805||||||F|||20160805
ORC|RE|1234^AIRA|F81S3495.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362
RXA|0|1|20160805||133^PCV13^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A1345C|20170430|PFR^Pfizer^MVX|||CP|A|
RXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163|
OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20160805
OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20160805|||VXC40^per immunization^CDCPHINVS
OBX|3|CE|69764-9^Document Type^LN|3|253088698300026411151105^Multi Pediatric Vaccines VIS^cdcgs1vis||||||F|||20160805
OBX|4|DT|29769-7^Date Vis Presented^LN|3|20160805||||||F|||20160805
ORC|RE|1234^AIRA|F81S3495.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362
RXA|0|1|20160805||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20170430|MSD^Merck and Co^MVX|||CP|A|
RXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163|
OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20160805
OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20160805|||VXC40^per immunization^CDCPHINVS
OBX|3|CE|69764-9^Document Type^LN|3|253088698300013411100521^Measles Mumps Rubella Varicella VIS^cdcgs1vis||||||F|||20160805
OBX|4|DT|29769-7^Date Vis Presented^LN|3|20160805||||||F|||20160805
ORC|RE|1234^AIRA|F81S3495.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362
RXA|0|1|20160805||83^Hep A peds^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||825AR23|20170430|SKB^GlaxoSmithKline^MVX|||CP|A|
RXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163|
OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20160805
OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20160805|||VXC40^per immunization^CDCPHINVS
OBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A VIS^cdcgs1vis||||||F|||20160805
OBX|4|DT|29769-7^Date Vis Presented^LN|3|20160805||||||F|||20160805